October 23, 1998
Cytolog Research Progress
Multiple Sclerosis experience:
C v de A, 48 year old woman. She was diagnosed with MS 18 years ago. She received multiple treatments (prednisone, carbamazepine, etc) with minimal or no improvement, so she stopped taking them about 3 years ago. The clinical course of disease was: she lost vision in left eye (disease initial setting), and subsequently other symptoms appeared affecting her left arm. Every 2 or 3 months she used to suffer from relapses, which included weakness, numbness, contractures affecting right arm also. On September 1997, she was referred to our office and decided to start Cytolog on January 1998. For the last 10 months she has been almost free from relapsing symptoms. She recovered right arm strength and function, and the disease seems to stabilize on her left arm disfunction. She also refers to be much more energetic, and has recovered normal activity in householding.
As we have been discussing with a group of neurologists about Cytolog's properties, we have prepared a protocol for an initial clinical observation with MS patients. Our target group are patients suffering from frequent relapses, which seems to be the most suitable group to show the Cytolog effect. Our hypothesis is that it is possible to stop disease progression in these patients. It will take us a couple of weeks to get an agreement with the neurologists to start this trial.
Alejandro & Fabiola Nitsch, MD